GlobalView

Pagani, Olivia

Statistics
Title Hits Visitors Downloads
Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials 293 263 0
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer 266 236 0
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials 13 10 0
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials 90 63 0
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93 172 157 0
Impact of CYO19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial 3 1 0
Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor–positive, human epidermal growth factor receptor 2–negative early breast cancer: TEXT and SOFT Trials 80 51 2
Repository Search URL

Pagani, Olivia

Formatted Bibliography URL

Pagani, Olivia

Bibliography Markup

To include a live feed of this author's bibliography on a static Web page (e.g., a personal home page), add the following HTML code to the body of your HTML.